The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells

Toxicology and Applied Pharmacology

Volumn 245, Issue 1, 2010, Pages 83-90

  Yu, Xinyuan ^a   Filardo, Edward J ^b   Shaikh, Zahir A ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Cadmium; Cell proliferation; Endocrine disruptors; Estrogen receptors; GPR30; SKBR3 cells

Indexed keywords

CADMIUM; CYCLIC AMP; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MUTANT PROTEIN; RAF PROTEIN; S6 KINASE; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FOLDING; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CADMIUM; CARCINOGENS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 77952550866     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.02.005     Document Type: Article

References (50)

1. Akesson A., Julin B., Wolk A. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res. 2008, 68:6435-6441.
2. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., Oprea T.I., Prossnitz E.R., Musti A.M., Andò S., Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67:1859-1866.
3. Albanito L., Sisci D., Aquila S., Brunelli E., Vivacqua A., Madeo A., Lappano R., Pandey D.P., Picard D., Mauro L., Andò S., Maggiolini M. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 2008, 149:3799-3808.
4. Antila E., Mussalo-Rauhamma H., Kantola M., Atroshi F., Westermarck T. Association of cadmium with human breast cancer. Sci. Total Environ. 1996, 186:251-256.
5. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., Mariani S., Cherubini S., d'Abusco A.S., Scandurra R., Migliaccio S. Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol. Cell. Endocrinol. 2007, 264:102-108.
6. Byrne C., Divekar S.D., Storchan J.B., Paroda D.A., Martin M.B. Cadmium - a metallohormone?. Toxicol. Appl. Pharmacol. 2009, 238:266-271.
7. Cantor K.P., Stewart P.A., Brinton L.A. Occupational exposure and female breast cancer mortality in the United States. J. Occup. Med. 1994, 37:336-348.
8. Fell G.S., Ottaway J.M., Hussein F.E. Application of blood cadmium analysis to industry using an atomic fluorescence method. Br. J. Ind. Med. 1977, 34:106-109.
9. Filardo E.J., Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab. 2005, 16:362-367.
10. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
11. Filardo E., Quinn J., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007, 148:3236-3245.
12. Funakoshi T., Yanai A., Shinoda K., Kawano M.M., Mizukami Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun. 2006, 346:904-910.
13. Garcia-Morales P., Saceda M., Kenney N., Kim N., Salomon D.S., Gottardis M.M., Solomon H.B., Sholler P.F., Jordan V.C., Martin M.B. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J. Biol. Chem. 1994, 269:16896-16901.
14. Gilad L.A., Bresler T., Gnainsky J., Smirnoff P., Schwartz B. Regulation of vitamin D receptor expression via estrogen-induced activation of the Erk 1/2 signaling pathway in colon and breast cancer cells. J. Endocrinol. 2005, 185:577-592.
15. Hennessy B.A., Harvey B.J., Healy V. 17beta-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells. Mol. Cell. Endocrinol. 2005, 229:39-47.
16. Herrmann R., Heck M., Henklein P., Kleuss C., Hofmann K.P., Ernst O.P. Sequence of interactions in receptor-G protein coupling. J. Biol. Chem. 2004, 279:24283-24290.
17. Herynk M.H., Fuqua S.A. Estrogen receptor mutations in human disease. Endocr. Rev. 2004, 25:869-898.
18. Huff J., Lunn R.M., Waalkes M.P., Tomatis L., Infante P.F. Cadmium-induced cancers in animals and in humans. Int. J. Occup. Environ. Health 2007, 13:202-212.
19. Ikeda K., Inoue S. Estrogen receptors and their downstream targets in cancer. Arch. Histol. Cytol. 2004, 67:435-442.
20. Jin Y.H., Clark A.B., Slebos R.J., Al-Refai H., Taylor J.A., Kunkel T.A., Resnick M.A., Gordenin D.A. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat. Genet. 2003, 34:326-329.
21. Johnson M.D., Kenney N., Stoica A., Hilakivi-Clarke L., Singh B., Chepko G., Clarke R., Sholler P.F., Lirio A.A., Foss C., Reiter R., Trock B., Paik S., Martin M.B. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med. 2003, 9:1081-1084.
22. Karnik S.S., Gogonea C., Patil S., Saad Y., Takezako T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol. Metab. 2003, 14:431-437.
23. Kleuser B., Malek D., Gust R., Pertz H.H., Potteck H. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. Mol. Pharmacol. 2008, 74:1533-1543.
24. Liu Z., Yu X., Shaikh Z.A. Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium. Toxicol. Appl. Pharmacol. 2008, 228:286-294.
25. Lobenhofer E.K., Huper G., Iglehart J.D., Marks J.R. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ. 2000, 11:99-110.
26. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 3:281-292.
27. May L.T., Avlani V.A., Sexton P.M., Christopoulos A. Allosteric modulation of G protein-coupled receptors. Curr. Pharm. Des. 2004, 10:2003-2013.
28. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., Chang F., Lehmann B., Terrian D.M., Milella M., Tafuri A., Stivala F., Libra M., Basecke J., Evangelisti C., Martelli A.M., Franklin R.A. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta 2007, 1773:1263-1284.
29. McElroy J.A., Shafer M.M., Trentham-Dietz A., Hampton J.M., Newcomb P.A. Cadmium exposure and breast cancer risk. J. Natl. Cancer Inst. 2006, 98:869-873.
30. Pandey D.P., Lappano R., Albanito L., Madeo A., Maggiolini M., Picard D. Estrogenic GPR30 signaling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28:523-532.
31. Pang Y., Dong J., Thomas P. Estrogen signaling characteristics of Atlantic croaker GPR30 and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology 2008, 149:3410-3426.
32. Prossnitz E.R., Arterburn J.B., Sklar L.A. GPR30: a G protein-coupled receptor for estrogen. Mol. Cell. Endocrinol. 2007, 265-266. 138-142.
33. Quinn J.A., Graeber C.T., Frackelton A.R., Kim M., Schwarzbauer J.E., Filardo E.J. Coordinated regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30. Mol. Endocrinol. 2009, 23:1052-1064.
34. Razandi M., Pedram A., Rosen E.M., Levin E.R. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol. Cell. Biol. 2004, 24:5900-5913.
35. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
36. Rollerova E., Urbancikova M. Intracellular estrogen receptors, their characterization and function (Review). Endocr. Regul. 2000, 34:203-218.
37. Russo J., Russo I.H. The role of estrogen in the initiation of breast cancer. J. Steroid Biochem. Mol. Biol. 2006, 102:89-96.
38. Safe S. Cadmium's disguise dupes the estrogen receptor. Nat. Med. 2003, 9:1000-1001.
39. Satoh M., Koyama H., Kaji T., Kito H., Tohyama C. Perspectives on cadmium toxicity research. Tohoku J. Exp. Med. 2002, 196:23-32.
40. Shaikh Z.A., Smith J.C. Metabolism of orally ingested cadmium in humans. Dev. Toxicol. Environ. Sci. 1980, 8:569-574.
41. Stewart P.J., Webster R.A. Intrauterine injection of cholera toxin induces estrogen-like uterine growth. Biol. Reprod. 1983, 29:671-679.
42. Stoica A., Katzenellenbogen B.S., Martin M.B. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol. Endocrinol. 2000, 14:545-553.
43. Takiguchi M., Yoshihara S. New aspects of cadmium as endocrine disruptor. Environ. Sci. 2006, 13:107-116.
44. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
45. Ursin G., Bernstein L., Pike M.C. Breast cancer. Cancer Surveys 1994, 241-264. Cold Spring Harbor Laboratory Press, Plainview, NY. R. Doll, J.F. Fraumeni, C.S. Muir (Eds.).
46. Verougstraete V., Lison D., Hotz P. Cadmium, lung and prostate cancer: a systematic review of recent epidemiological data. J. Toxicol. Environ. Health B Crit. Rev. 2003, 6:227-255.
47. Waalkes M.P. Cadmium carcinogenesis in review. J. Inorg. Biochem. 2000, 79:241-244.
48. Waalkes M.P. Cadmium carcinogenesis. Mutat. Res. 2003, 533:107-120.
49. Wood J.R., Greene G.L., Nardulli A.M. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol. Cell. Biol. 1998, 18:1927-1934.
50. Zhang W., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002, 12:9-18.